Sarepta Therapeutics, Inc.
SRPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,103 | $428 | $967 | $2,116 |
| Short-Term Investments | $252 | $1,248 | $1,023 | $0 |
| Receivables | $650 | $437 | $262 | $173 |
| Inventory | $750 | $323 | $204 | $186 |
| Other Curr. Assets | $9 | $12 | $7 | $5 |
| Total Curr. Assets | $3,073 | $2,579 | $2,558 | $2,604 |
| Property Plant & Equip (Net) | $489 | $357 | $245 | $237 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $27 | $30 | $8 | $14 |
| Long-Term Investments | $137 | $7 | $31 | $35 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $237 | $292 | $287 | $258 |
| Total NC Assets | $890 | $685 | $571 | $544 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,963 | $3,265 | $3,128 | $3,148 |
| Liabilities | – | – | – | – |
| Payables | $214 | $165 | $96 | $77 |
| Short-Term Debt | $0 | $105 | $0 | $0 |
| Tax Payable | $17 | $14 | $13 | $0 |
| Deferred Revenue | $130 | $50 | $89 | $89 |
| Other Curr. Liab. | $200 | $179 | $135 | $110 |
| Total Curr. Liab. | $732 | $654 | $620 | $453 |
| LT Debt | $1,137 | $1,133 | $1,544 | $1,097 |
| Deferred Rev, NC | $325 | $437 | $485 | $574 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $49 | $41 | $37 | $55 |
| Total NC Liab. | $1,704 | $1,752 | $2,124 | $1,767 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $206 | $159 | $73 | $57 |
| Total Liabilities | $2,435 | $2,405 | $2,743 | $2,220 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$4,211 | -$4,446 | -$3,910 | -$3,207 |
| AOCI | -$0 | $1 | -$2 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $1,528 | $859 | $385 | $928 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,963 | $3,265 | $3,128 | $3,148 |
| Net Debt | $34 | $810 | $578 | -$1,019 |